Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular Availability of 1.5% Levofloxacin in Human Tears
NCT00703313Phase 4Completed
- Sponsor
- Santen Pharmaceutical
- Start
- May 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levofloxacin in bacterial keratitis (3 arms), sponsored by Santen Pharmaceutical. Primary endpoint: Concentration of levofloxacin, moxifloxacin or gatifloxacin in tears at 24 hours. Started May 2008; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial keratitis
Beyond the preview
Go deeper on NCT00703313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703313.